Search Results 2211-2220 of 2837 for site:slotspk17.com

1. JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

2. Study of VS-6766 + Adagrasib in KRAS G12C NSCLC Patients - Mayo Clinic

   The purpose of this study is to assess the safety and effectiveness of Avutometinib combined with adagrasib in patients with G12C Non-Small Cell Lung Cancer ( ...

3. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

4. Microfragmented Adipose Tissue Compared to Corticosteroid Injection for the Treatment of Knee Osteoarthritis (ARISE) - Mayo Clinic

   The purpose of this study is to examine the effect of examine the effect of a single autologous, intra-articular injection of MFat versus corticosteroid ...

5. A Study to Evaluate the Safety of ART352-L in Subjects Undergoing Posterolateral Spinal Fusion - Mayo Clinic

   The primary purpose of this study is to evaluate the safety and tolerability of ART352-L treated local bone autograft in subjects undergoing a spinal fusion ...

6. A Study Of NT-112 In HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, And/ Or Metastatic Solid Tumors Positive For The KRAS G12D Mutation - Mayo Clinic

   A Study Of NT-112 In HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, And/ Or Metastatic Solid Tumors Positive For The KRAS G12D Mutation · Share ...

7. A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma - Mayo Clinic

   About this study. The purpose of this trial is to evaluate the safety, tolerability, immunogenicity, pharmacokinetics (PK), pharmacodynamics (PD), ...

8. Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   About this study. The purpose of this study is to establish the Recommended Phase 2 Dose (RP2D), safety, pharmacokinetics (PK), pharmacodynamics (PD), ...

9. A Study To Assess The Safety And Tolerability Of CFT7455 In Relapsed/Refractory Non-Hodgkin's Lymphoma Or Multiple Myeloma - Mayo Clinic

   About this study. The purpose of this study is to characterize the safety, tolerability, pharmacokinetics, pharmacodynamics, and antitumor activity of ...

10. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...